|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 4/18/2023 3:48:50 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Consolidated Appropriations Act of 2023, provisions relating to Telehealth flexibilities
Fiscal Year 2024 Appropriations, provisions relating to CDC Data Modernization Initiative (DMI), Post-Intensive Care Syndrome/research and treatment funding, Childrens Hospitals Graduate Medical Education (CHGME) Payment Program/funding
HHS Budget/MEI update/MACRA/APMs
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 704, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 1202, Resident Education Deferred Interest (REDI) Act, all provisions
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 2389, To amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes, all provisions
H.R. 880, Heart Health Enhancement through Access to Research and Training (HEART) Act, all provisions
Medical Student Education Authorization Act, all provisions
Indian Health Service Health Professions Tax Fairness Act, all provisions
Resident Physician Shortage Reduction Act, (Senate draft) all provisions
Strengthening Americas Health Care Readiness Act, all provisions
Public Service Loan Forgiveness (PSLF) Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Christopher |
Sherin |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 127, Pharmacy Benefit Manager Transparency Act of 2023, all provisions
S. 113, Prescription Pricing for the People Act of 2023, all provisions
H.R. 830, Help Ensure Lower Patient (HELP) Copays Act, all provisions
H.R. 618, Improving Access to Workers Compensation for Injured Federal Workers Act, provisions relating to scope of practice
S. 131, Improving Access to Workers Compensation for Injured Federal Workers Act, provisions relating to scope of practice
S. 669, Increasing Mental Health Options Act of 2023, all provisions
H.R. 382, Pandemic is Over Act, all provisions
S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
Black Maternal Health Momnibus Act, all provisions
No Surprises Act/Implementation
Medication Access and Training Expansion (MATE) Act/Implementation
21st Century Cures Act/implementation
Pandemic and All-Hazards Preparedness Reauthorization Act (PAHPRA), all provisions
Integrating social workers across health care settings act/draft
Strengthening Americas Health Care Readiness Act, provisions relating to funding for National Health Service Corps and demonstration project
Pharmacy Benefit Manager
Maternal mortality/Access to care
Mental health parity/Physician burnout
Physician workforce issues
Cybersecurity/Information Blocking
Unique Device Identifier issues
Telehealth flexibility/permanent expansion
Health equity
Clinical Algorithms/Bias/Discrimination
Prior Authorization
Data Privacy/patient control
HIPAA/EHR
Primary health care
Child Nutrition Meal Standards
WIC Nutrition Program
Air pollution/Oil and Gas
Augmented Intelligence (AI) Taxonomy
Reproductive health services
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Drug Enforcement Administration (DEA), Office of Natl Drug Control Policy (NDCP), Food & Drug Administration (FDA), Environmental Protection Agency (EPA), Substance Abuse & Mental Health Services Administration (SAMHSA), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
S. 665, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Healthcare Workforce Resilience Act, all provisions
Family Detention
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Alexis |
Pierce |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 113, Prescription Pricing for the People Act of 2023, all provisions
Insurance market competition
Pharmacy Benefit Manager market competition
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Chase |
Thomas |
|
|
|
George |
Cox |
III |
|
|
Ashley |
Delosh |
|
|
|
Lisa |
Myers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 751, Fair Access In Residency (FAIR) Act, all provisions
H.R. 1610, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
S. 799, Chiropractic Medicare Coverage Modernization Act of 2023, all provisions
H.R. 2474, To amend title XVIII of the Social Security Act to provide for an update to a single conversion factor under the Medicare physician fee schedule that is based on the Medicare economic index, all provisions
H.R. 2389, To amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes, all provisions
S. 703, Physicians for Underserved Areas Act, provisions pertaining to emergency department residency shortages
H.R. 977, Patient Access to Higher Quality Health Care Act of 2023, all provisions
S. 470, Patient Access to Higher Quality Health Care Act of 2023, all provisions
H.R. 1694, Emergency Care Improvement Act, provisions relating to emergency rooms
H.R. 1745, Medicare Fraud Detection and Deterrence Act of 2023, all provisions
H.R. 1746, Preventing Medicare Telefraud Act, all provisions
H.R. 497, Freedom for Health Care Workers Act, all provisions
H.R. 704, Promoting Access to Diabetic Shoes Act, all provisions
S. 669, Increasing Mental Health Options Act of 2023, all provisions
Medicare program: Improving Seniors Timely Access to Care Act of 2022, all provisions/CBO score
Medicare program: Value in Health Care Act, provisions relating to Alternative Payment Models (APMs)
Medicare program: CONNECT for Health Act, all provisions
Medicare program: Resident Physician Shortage Reduction Act, (Senate draft) all provisions
Medicare program: Opioid Workforce Act, all provisions
Medicare program: Substance Use Disorder Workforce Act, all provisions
Medicare program: Safe Step Act, all provisions
Medicare program: Improving Care and Access to Nurses (ICAN) Act, all provisions
Medicare program: Equitable Community Access to Pharmacist Services Act, provisions related to scope of practice
Medicare program: HHS Budget/MEI update/MACRA/APMs
Medicare program: Medicare physician payment reform
Medicare program: Add-on Code
Medicare program: Medicare Economic Index (MEI)/MedPAC recommendations
Medicare program: Budget neutrality
Medicare program: Medicare Advantage cuts/Advanced Rate Notice
Medicare program: Physician workforce issues
Medicare program: Physician owned hospitals/stand-alone emergency rooms
Medicare program: Prior Authorization
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: MIPS Value Pathways improvement
Medicare program: Electronic Health Records (EHR) certification
Medicare program: Quality Payment Program/MIPS/Quality/Cost/Promoting Interoperability/Improvement Activities
Medicare program: Quality Payment Program/physician burdens
Medicare program: Data sharing
Medicare program: Patient engagement
Medicare program: Provider Compliance and Regulatory Relief
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS) Enrollment/Revalidation
Medicare program: Open Payments
Medicare program: Coding
Medicare program: Telehealth flexibility/extension
Medicare and Medicaid programs: Medicare Access and CHIP Reauthorization (MACRA) Act/broad reform
Medicare and Medicaid programs: MACRA/Physician burdens
Medicare and Medicaid programs: Cybersecurity/Information Blocking
Medicare and Medicaid programs: Data Privacy/patient control
Medicare and Medicaid programs: HIPAA/EHR
Medicaid program: Maternal health
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Lindsey |
Brill |
|
|
|
Katherine |
Dapper |
|
|
|
Dana |
Lichtenberg |
|
|
|
Christopher |
Sherin |
|
|
|
Chase |
Thomas |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jeffrey |
Coughlin |
|
|
|
Shannon |
Curtis |
|
|
|
Jennifer |
Hananoki |
|
|
|
Suzanne |
Joy |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
Delosh |
|
|
|
Bryan |
Hull |
|
|
|
Lisa |
Myers |
|
|
|
Alexis |
Pierce |
|
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Indian Health Service Health Professions Tax Fairness Act, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Christopher |
Sherin |
|
|
|
George |
Cox |
III |
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Non-menthol cigarette products
Smoke-free VHA facilities
17. House(s) of Congress and Federal agencies Check if None
Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 10, VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023, all provisions
Honoring our PACT Act
VA Supremacy Project/Scope
Veterans Choice/Community Care Program
VHA/Smoke-free facilities
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Todd |
Askew |
|
|
|
Cynthia |
Brown |
|
|
|
Jason |
Marino |
|
|
|
Katherine |
Dapper |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |